BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
13 results:

  • 1. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
    Jiang Z; Wang H; Wang S; Guan C; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal.
    Wei H; Li Z; Zhao Y; Zhu S; Wen S; Quan C
    Cancer Rep (Hoboken); 2023 Aug; 6(8):e1824. PubMed ID: 37344930
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
    Kim SH; Park J; Park WS; Hong D; Chung J
    Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
    Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
    Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
    Shin TJ; Song C; Jeong CW; Kwak C; Seo S; Kang M; Chung J; Hong SH; Hwang EC; Park JY; Lee H
    J Surg Oncol; 2021 Jan; 123(1):204-213. PubMed ID: 33047324
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran.
    Alamdari NM; Afaghi S; Rahimi FS; Tarki FE; Tavana S; Zali A; Fathi M; Besharat S; Bagheri L; Pourmotahari F; Irvani SSN; Dabbagh A; Mousavi SA
    Tohoku J Exp Med; 2020 Sep; 252(1):73-84. PubMed ID: 32908083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
    Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
    Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
    Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
    Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course.
    Ueno D; Yao M; Tateishi U; Minamimoto R; Makiyama K; Hayashi N; Sano F; Murakami T; Kishida T; Miura T; Kobayashi K; Noguchi S; Ikeda I; Ohgo Y; Inoue T; Kubota Y; Nakaigawa N
    BMC Cancer; 2012 May; 12():162. PubMed ID: 22551397
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
    Motzer RJ; Hutson TE; Tomczak P; Michaelson MD; Bukowski RM; Oudard S; Negrier S; Szczylik C; Pili R; Bjarnason GA; Garcia-del-Muro X; Sosman JA; Solska E; Wilding G; Thompson JA; Kim ST; Chen I; Huang X; Figlin RA
    J Clin Oncol; 2009 Aug; 27(22):3584-90. PubMed ID: 19487381
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.